Metraipolis › archive › dc_229409b4309c

CD26 as a potential therapeutic target for lung adenocarcinoma — Europe PMC PMID:41426321

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41426321
DOI
10.3389/fonc.2025.1552587
License (as archived)
solo-consultazione
Archived
2026-11-07T22:31:29.132Z
SHA-256 of the archived text
37a171d426405c92cf4639d486d3e59fd9a837784dad19aa882cc199221507de
Stable URL of this page
https://metraipolis.com/documento/dc_229409b4309c

How to cite

CD26 as a potential therapeutic target for lung adenocarcinoma — Europe PMC PMID:41426321 — Europe PMC (en), https://europepmc.org/article/MED/41426321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_229409b4309c (Metraipolis archive dc_229409b4309c, sha256 37a171d426405c92cf4639d486d3e59fd9a837784dad19aa882cc199221507de)
BibTeX
@misc{dc229409b4309c,
  title = {CD26 as a potential therapeutic target for lung adenocarcinoma — Europe PMC PMID:41426321},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41426321},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_229409b4309c; sha256 37a171d426405c92cf4639d486d3e59fd9a837784dad19aa882cc199221507de},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426321. Agents can read the archived copy with the MCP tool read_document.